The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.

R. Rittmaster,L. Thomas,A. Wright,S. K. Murray,K. Carlson,R. Douglas,J. Yung,M. Messieh,D. Bell,C. Lazier

DOI: https://doi.org/10.1016/S0022-5347(05)68153-0

1999-12-01

Abstract:

What problem does this paper attempt to address?

295 High Volume Centers Provide Superior Value of Care in the Surgical Treatment of Malignant Brain Tumor

Sima Vazquez,Jose Fernando Dominguez,Eris Spirollari,Sauson Soldozy,Michael E. Ivan,Martin Andres Merenzon,Simon Jeremy Hanft,Ricardo Jorge Komotar

DOI: https://doi.org/10.1227/neu.0000000000002809_295

IF: 5.315

2024-04-01

Neurosurgery

Abstract:INTRODUCTION: Improved outcomes in surgical patients have been associated with increasing volume of cases. This has led to the development of centers that facilitate care for a specific patient population. METHODS: The 2016-2020 National Inpatient Sample (NIS) was queried for patients undergoing resection of malignant brain tumors. Teaching hospitals with high case load (greater than two standrad deviations above the mean, or >140 cases) were categorized as high-volume centers (HVC). Value of care was computed by adding one point for each of the following variables: lower length of stay, lower total charges, discharge to home, and lack of major comorbidity or complication, as defined per DRG codes. RESULTS: A total of 118,390 patients underwent resection of malignant brain tumors in 3,009 hospitals. HVC criteria was met by 91 (3%) hospitals, which represented 20,230 (17.1%) of total cases. The Mid-Atlantic and South Atlantic regions had the highest percentage of cases (22.7% and 20.2%, respectively) and number of HVC (21 and 17, respectively). Value of care was higher at HVC (OR = 1.35 95%CI 1.31-1.39 p < 0.01). After controlling for baseline risk factors and high risk admissions, HVC was associated with decreased complications of intracranial hemorrhage, deep venous thrombosis, aspiration pneumonitis, acute kidney injury, and external ventricular drain requirement (p < 0.01 for all). HVC was also associated with decreased length of stay and increased rate of discharge to home (p < 0.01 for both). CONCLUSIONS: Patients undergoing craniotomy for malignant brain neoplasms have superior outcomes in HVC. Trends of centralization are likely a reflection of the benefits of multidisciplinary treatment for these patients. Improvement of access to care at these institutions may improve the efficiency of the delivery of care for these patients.

surgery,clinical neurology
Characteristics and outcomes of patients treated with cervical spine fusion at high volume hospitals

Sima Vazquez,Jose F. Dominguez,Victor M. Lu,Vignessh Kumar,Sumedh Shah,G. Damian Brusko,Allan D. Levi

DOI: https://doi.org/10.1016/j.wneu.2024.04.115

IF: 2.21

2024-04-27

World Neurosurgery

Abstract:Background High volume (HV) has been associated with improved outcomes in various neurosurgical procedures. The objective of this study was to explore the regional distribution of HV spine centers for cervical spine fusion, and compare characteristics and outcomes or patients treated at HV centers versus lower volume centers. Methods The National Inpatient Sample (NIS) database 2016-2020 was queried for patients undergoing cervical spine fusion for degenerative pathology. High volume (HV) was defined as case-loads greater than two standard deviations above the mean. Patient characteristics, procedures, and outcomes were compared. Results Of 3,895 hospitals performing cervical spine fusion, 28 (0.76%) were HV. The Mid-Atlantic and West South Central region had the highest number of HV hospitals. HV hospitals were more likely to perform open anterior fusion surgeries (p < 0.01). Patients treated at HV hospitals were less likely to have severe symptomatology or comorbidities (p < 0.01 for all). When controlling for severity and demographics on multivariate analysis, HV centers had higher odds of length of stay ≤ 1 day, favorable discharge, and decreased total charges. Conclusion Patients who underwent cervical spine fusion surgery at high-volume hospitals were less complex and had increased odds of LOS ≤ 1, favorable discharge, and total charges in the lower 25th percentile than patients treated at non high-volume hospitals. Physician comfort, patient selection, institutional infrastructure, and geographic characteristics likely play a role.

surgery,clinical neurology
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection

Jane S. Han,Talia Wenger,Alexandra N. Demetriou,Jonathan Dallas,Li Ding,Gabriel Zada,William J. Mack,Frank J. Attenello

DOI: https://doi.org/10.1007/s11060-024-04800-5

2024-09-14

Journal of Neuro-Oncology

Abstract:Improved outcomes have been noted in patients undergoing malignant brain tumor resection at high-volume centers. Studies have arbitrarily chosen high-volume dichotomous cutoffs and have not evaluated volume-outcome associations at specific institutional procedural volumes. We sought to establish the continuous association of volume with patient outcomes and identify cutoffs significantly associated with mortality, major complications, and readmissions. We hypothesized that a linear volume-outcome relationship can estimate likelihood of adverse outcomes when comparing any two volumes.

oncology,clinical neurology
Drivers of Cost for Pancreatic Surgery: It’s Not About Hospital Volume

Sarah B. Bateni,Jennifer L. Olson,Jeffrey S. Hoch,Robert J. Canter,Richard J. Bold

DOI: https://doi.org/10.1245/s10434-018-6758-1

IF: 4.339

2018-09-14

Annals of Surgical Oncology

Abstract:BackgroundOutcomes for pancreatic resection have been studied extensively due to the high morbidity and mortality rates, with high-volume centers achieving superior outcomes. Ongoing investigations include healthcare costs, given the national focus on reducing expenditures. Therefore, we sought to evaluate the relationships between pancreatic surgery costs with perioperative outcomes and volume status.MethodsWe performed a retrospective analysis of 27,653 patients who underwent elective pancreatic resections from October 2013 to June 2017 using the Vizient database. Costs were calculated from charges using cost–charge ratios and adjusted for geographic variation. Generalized linear modeling adjusting for demographic, clinical, and operation characteristics was performed to assess the relationships between cost and length of stay, complications, in-hospital mortality, readmissions, and hospital volume. High-volume centers were defined as hospitals performing ≥ 19 operations annually.ResultsThe unadjusted mean cost for pancreatic resection and corresponding hospitalization was $20,352. There were no differences in mean costs for pancreatectomies performed at high- and low-volume centers [− $1175, 95% confidence interval (CI) − $3254 to $904, p = 0.27]. In subgroup analysis comparing adjusted mean costs at high- and low-volume centers, there was no difference among patients without an adverse outcome (− $99, 95% CI − $1612 to 1414, p = 0.90), one or more adverse outcomes (− $1586, 95% CI − $4771 to 1599, p = 0.33), or one or more complications (− $2835, 95% CI − $7588 to 1919, p = 0.24).ConclusionsWhile high-volume hospitals have fewer adverse outcomes, there is no relationship between surgical volume and costs, which suggests that, in itself, surgical volume is not an indicator of improved healthcare efficiency reflected by lower costs. Patient referral to high-volume centers may not reduce overall healthcare expenditures for pancreatic operations.

oncology,surgery
[Peptide histidine-isoleucine and and its human analogue peptide histidine-methionine: localization, receptors and biological function].

A. Dejda,I. Matczak,J. Nowak

2004-02-26

Postępy Higieny i Medycyny Doświadczalnej

Abstract:Peptide histidine-isoleucine (PHI) and its human analogue peptide histidine-methionine (PHM) are members of a superfamily of structurally related peptides embracing, among others, pituitary adenylate cyclase-activating polypeptide (PACAP), vasoactive intestinal peptide (VIP), peptide histidine-valine (PHV), and helodermin. All the peptides display a pleiotropic biological activity. PHI, PHM, PHV and VIP are co-synthesized from the same precursor and share high levels of structural and functional similarity. These peptides may act through common receptors and are widely distributed throughout the body tissues (the central nervous system, gastrointestinal tract, respiratory system, and reproductive system); however, their role remains largely unknown. Changes in the levels of the peptides in the course of different diseases suggest their possible importance and usefulness in diagnostics. Moreover, the neurotrophic and neuroprotective properties of PHI suggest, by analogy to VIP or PACAP, its therapeutic potential in many neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
114 Compliance with Federal Price Transparency Rules at US Hospitals With Neurosurgical Training Programs

Alexandra Giantini Larsen,Abhinav Pandey,Nalini Tata,W. Christopher Newman

DOI: https://doi.org/10.1227/neu.0000000000002809_114

IF: 5.315

2024-04-01

Neurosurgery

Abstract:INTRODUCTION: The Centers for Medicare & Medicaid Services implemented federal requirements on January 1st, 2021 that require hospitals to provide a list of payer-negotiated prices in a machine-readable file. METHODS: We performed a cross-sectional analysis in March of 2023 of 116 US hospitals associated with a neurosurgical training program to assess compliance with the new federal requirements by searching “price transparency” or “standard charges” with associated hospital on the internet to download machine readable files. The payer-negotiated price for 11 common neurosurgical procedures based on CPT codes for 4 insurance companies were collected (Aetna,Anthem/BCBS,United,Medicare). Pricing using DRG codes were excluded given the range of neurosurgical procedures that are encompassed by a specific DRG code. RESULTS: 92/116 (79.3%) hospitals were compliant with the requirement for machine-readable file with payer-negotiated prices. 45/92 (48.9%) used DRG codes. For the common neurosurgical procedures, hospitals had negotiated price available for at least one insurance company with average private insurance cost and average Medicare costs as follows: ventriculoperitoneal shunt (21/92;$10,698;$1,919), lumbar laminectomy (20/92;$10,343;$4,460), lumbar microdiscectomy (31/92;$9,374;$5,026), anterior cervical discectomy and fusion (28/92;$11,544;$9,859), deep brain stimulator with microelectrode recording (15/92;$10,510;$3,616), craniotomy for tumor (14/92;$6,951;$2,361), stereotactic radiosurgery for brain (18/92;$22,409;$7,362) and spine (14/92;$14,242;$3,306), intrathecal pump placement (31/92;$7,139;$5,064), intracranial aneurysm endovascular treatment (14/92;$9,452;$3352), and diagnostic angiogram (46/92;$11,295;$5,867). CONCLUSIONS: While hospital compliance with federal requirement for machine readable files with payer-negotiated prices was high, availability of payer-negotiated prices for 4 major insurance types across 11 common neurosurgical procedures based on CPT code was sparce. Overall, meaningful conclusions on procedural related cost for elective procedures will be difficult for patients to make due to the unintelligible format of data and a lack of reporting of cost per CPT code in a comprehensive manner.

surgery,clinical neurology
Volume Alone Does Not Predict Quality Outcomes in Hospitals Performing Pediatric Cardiac Surgery

Dhaval Chauhan,J. Hunter Mehaffey,J. W. Awori Hayanga,Jai P. Udassi,Vinay Badhwar,Christopher E. Mascio

DOI: https://doi.org/10.1016/j.athoracsur.2024.01.006

IF: 5.113

2024-01-29

The Annals of Thoracic Surgery

Abstract:BACKGROUND Lower institutional volume has been associated with inferior pediatric cardiac surgery outcomes. This study explored the variation in mortality rates among low-, mid-, and high-volume hospitals performing pediatric cardiac surgery in the United States. METHODS The Kids' Inpatient Database (KID) was explored for the years 2016 and 2019. Hospitals only performing off-bypass coarctation and ventricular septal defect repair were omitted. The hospitals were divided into three groups by their annual case volume. Multivariable logistic regression models were fit to obtain risk adjusted in-hospital mortality rates. RESULTS A total of 25,749 operations performed by 235 hospitals were included in the study. The risk-adjusted mortality rate for the entire sample was 1.9%. There were 140 hospitals in the low-volume group, 64 hospitals in the mid-volume group, and 31 in the high-volume group. All groups had low-mortality (mortality 1.9%). Among low volume hospitals, 53% were low-mortality (n=74) and 47% were high-mortality hospitals (n=66). Among mid-volume hospitals, 58% were low-mortality (n=37) and 42% of hospitals were high-mortality hospitals (n=27). Among high-volume hospitals, 68% were low-mortality (n=21) and 32% were high-mortality hospitals (n=10). There was no statistically significant difference in risk-adjusted in-hospital mortality when comparing low, mid and high-volume centers for seven STS benchmark procedures. CONCLUSIONS This national, real-world, risk-adjusted volume outcome analysis highlights that volume alone may not be the sole arbiter to predict quality of pediatric cardiac surgery outcomes. Using case volume alone as a surrogate for quality may unfairly asperse high-performing, low-volume programs.

surgery,cardiac & cardiovascular systems,respiratory system
Hospital resources are associated with value-based surgical performance

Richard S Hoehn,Dennis J Hanseman,Derek Go,Koffi Wima,Alex Chang,Audrey E Ertel,Shimul A Shah,Daniel E Abbott

DOI: https://doi.org/10.1016/j.jss.2016.04.024

Abstract:Background: We have previously shown that inferior outcomes at safety-net hospitals are largely dependent on hospital factors. We hypothesized that hospitals providing "high value" care (low cost and better outcomes) would have advantages in human and financial resources. Methods: The University HealthSystems Consortium Clinical Database and the American Hospital Association Annual Survey were used to examine hospitals performing eight complex surgical procedures from 2009 to 2013. Hospitals in the lowest quartiles of both mortality rate and cost were characterized as high value (n = 45), whereas those in the highest quartiles of both cost and mortality were low value (n = 45). Hospital size, staffing, and financial characteristics were compared between these two groups. Results: On average, high-value hospitals had lower proportions of Medicaid patient days (17% versus 30%; P < 0.01), higher proportions of outpatient surgery (63% versus 53%; P < 0.01), and spent more on capital expenditures per bed ($155,710 versus $62,434; P < 0.05). Also, high-value hospitals employed more hospitalists (0.08 versus 0.04 per bed; P < 0.01), had more privileged physicians (2.04 versus 1.25 per bed; P < 0.01), and had more full-time equivalent personnel (8.48 versus 6.79 per bed; all P < 0.05). As a result, these hospitals appeared to be more efficient; high-value hospitals had more total admissions per bed (46 versus 38; P < 0.01), fewer days per admission (5.20 versus 5.77; P < 0.01), and more inpatient surgeries per bed (15.7 versus 12.6; all P < 0.05). Conclusions: Hospitals that invest in more human resources and demonstrate increased throughput perform complex surgery at higher "value" (i.e., lower costs and mortality). Value-based purchasing initiatives that link hospital reimbursement to unadjusted surgical outcomes may exacerbate, rather than improve, disparities in surgical care that currently exist.
Demystifying the association of center-level operative trauma volume and outcomes of emergency general surgery

Amulya Vadlakonda,Nam Yong Cho,Zachary Tran,Joanna Curry,Sara Sakowitz,Jeffrey Balian,Troy Coaston,Areti Tillou,Peyman Benharash

DOI: https://doi.org/10.1016/j.surg.2024.03.045

IF: 4.348

2024-05-19

Surgery

Abstract:Background Recent studies have demonstrated a positive volume-outcome relationship in emergency general surgery. Some have advocated for the sub-specialization of emergency general surgery independent from trauma. We hypothesized inferior clinical outcomes of emergency general surgery with increasing center-level operative trauma volume, potentially attributable to overall hospital quality. Methods Adults (≥18 years) undergoing complex emergency general surgery operations (large and small bowel resection, repair of perforated peptic ulcer, lysis of adhesions, laparotomy) were identified in the 2016 to 2020 Nationwide Readmissions Database. Multivariable risk-adjusted models were developed to evaluate the association of treatment at a high-volume trauma center (reference: low-volume trauma center) with clinical and financial outcomes after emergency general surgery. To evaluate hospital quality, mortality among adult hospitalizations for acute myocardial infarction was assessed by hospital trauma volume. Results Of an estimated 785,793 patients undergoing a complex emergency general surgery operation, 223,116 (28.4%) were treated at a high-volume trauma center. Treatment at a high-volume trauma center was linked to 1.19 odds of in-hospital mortality (95% confidence interval 1.12–1.27). Although emergency general surgery volume was associated with decreasing predicted risk of mortality, increasing trauma volume was linked to an incremental rise in the odds of mortality after emergency general surgery. Secondary analysis revealed increased mortality for admissions for acute myocardial infarction with greater trauma volume. Conclusion We note increased mortality for emergency general surgery and acute myocardial infarction in patients receiving treatment at high-volume trauma centers, signifying underlying structural factors to broadly affect quality. Thus, decoupling trauma and emergency general surgery services may not meaningfully improve outcomes for emergency general surgery patients. Our findings have implications for the evolving specialty of emergency general surgery, especially for the safety and continued growth of the acute care surgery model.

surgery
Does healthcare system device volume correlate with price paid for spinal implants: a cross-sectional analysis of a national purchasing database

Eli Cahan,Kelly McFarlane,Nicole Segovia,Amanda Chawla,James Wall,Kevin Shea

DOI: https://doi.org/10.1136/bmjopen-2021-057547

IF: 3.006

2022-04-26

BMJ Open

Abstract:Objectives: Amid continuously rising US healthcare costs, particularly for inpatient and surgical services, strategies to more effectively manage supply chain expenses are urgently necessary. Across industries, the 'economy of scale' principle indicates that larger purchasing volumes should correspond to lower prices due to 'bulk discounts'. Even as such advantages of scale have driven health system mergers in the USA, it is not clear whether they are being achieved, including for specialised products like surgical implants which may be more vulnerable to cost inefficiency. The objective of this observational cross-sectional study was to investigate whether purchasing volumes for spinal implants was correlated with price paid. Setting: USA. Participants: Market data based on pricing levels for spine implants were reviewed from industry implant price databases. Filters were applied to narrow the sample to include comparable institutions based on procedural volume, patient characteristics and geographical considerations. Information on the attributes of 619 health systems representing 12 471 provider locations was derived from national databases and analytics platforms. Primary outcome measure: Institution-specific price index paid for spinal implants, normalised to the national average price point achieved. Results: A Spearman's correlation test indicated a weak relationship between purchasing volume and price index paid (ρ=-0.35, p<0.001). Multivariable linear regression adjusting for institutional characteristics including type of hospital, accountable care organisation status, payer-mix, geography, number of staffed beds, number of affiliated physicians and volume of patient throughput also did not exhibit a statistically significant relationship between purchasing volume and price index performance (p=0.085). Conclusions: National supply chain data revealed that there was no significant relationship between purchasing volume and price paid by health systems for spinal implants. These findings suggest that factors other than purchasing or patient volume are responsible for setting prices paid by health systems to surgical vendors and/or larger healthcare systems are not negotiating in a way to consistently achieve optimal pricing.
High-Volume Hospital Had Lower Mortality of Severe Intracerebral Hemorrhage Patients

Sang-Won Park,James Jisu Han,Nam Hun Heo,Eun Chae Lee,Dong-Hun Lee,Ji Young Lee,Boung Chul Lee,Young Wha Lim,Gui Ok Kim,Jae Sang Oh

DOI: https://doi.org/10.3340/jkns.2023.0205

2024-03-04

Journal of Korean Neurosurgical Society

Abstract:Objective: Intracerebral hemorrhage (ICH) accompanies higher mortality rates than other type of stroke. This study aimed to investigate the association between hospital volume and mortality for cases of ICH.Methods: We used nationwide data from 2013 to 2018 to compare high-volume hospitals (≥32 admissions/year) and low-volume hospitals (<32 admissions/year). We tracked patients' survival at 3-month, 1-year, 2-year, and 4-year endpoints. The survival of ICH patients was analyzed at 3-month, 1-year, 2-year, and 4-year endpoints using Kaplan-Meier survival analysis. Multivariable logistic regression analysis and Cox regression analysis were performed to determine predictive factors of poor outcomes at discharge and death.Results: Among 9,086 ICH patients who admitted to hospital during 18-month period, 6,756 (74.4%) and 2,330 (25.6%) patients were admitted to high-volume and low-volume hospitals. The mortality of total ICH patients was 18.25%, 23.87%, 27.88%, and 35.74% at the 3-month, 1-year, 2-year, and 4-year, respectively. In multivariate logistic analysis, high-volume hospitals had lower poor functional outcome at discharge than low-volume hospitals (odds ratio, 0.80; 95% confidence interval, 0.72-0.91; p < 0.001). In the Cox analysis, high-volume hospitals had significantly lower 3-month, 1-year, 2-year, and 4-year mortality than low-volume hospitals (p < 0.05).Conclusion: The poor outcome at discharge, short- and long-term mortality in ICH patients differed according to hospital volume. High-volume hospitals showed lower rates of mortality for ICH patients, particularly those with severe clinical status.

surgery,clinical neurology
The Nationwide Burden of Neurological Conditions Requiring Emergency Neurosurgery

Rafael De la Garza Ramos,C Rory Goodwin,Jonathan Nakhla,Rani Nasser,Reza Yassari,Eugene S Flamm,Ali Bydon,Geoffrey Colby,Daniel M Sciubba,C. Rory Goodwin,Eugene S. Flamm,Daniel M. Sciubba

DOI: https://doi.org/10.1093/neuros/nyx055

IF: 5.315

2017-03-10

Neurosurgery

Abstract:BACKGROUND: Neurosurgical emergencies are an important cause of disability and mortality.OBJECTIVE: To examine the nationwide burden of neurological conditions requiring emergency neurosurgery.METHODS: The Nationwide Inpatient Sample database (2002-2011) was queried to identify adult patients with a primary discharge diagnosis of a neurosurgical condition who were admitted urgently/emergently or through a trauma center and underwent surgical intervention within 2 days of admission. Diagnostic groups were ranked based on their inpatient complication and mortality burden, and their contribution to total complications, deaths, hospital charges, and length of stay (LOS) was assessed. All analyses were weighted to produce national estimates.RESULTS: After application of discharge weights, 810 404 patients who underwent emergency neurosurgery were identified. The average complication rate for the entire sample was 8.8%, the mortality rate was 11.2%, average charges were $106 802, and average LOS was 9.0 days. The top 4 diagnostic groups ranked by complication/mortality burden accounted for 76% of all complications, 96% of all deaths, 81% of all charges, and 82% of all days in the hospital for the entire study sample. This was equal to 62 648 complications, 86 683 deaths, $69 billion in charges, and 5962 932 days. These 4 diagnostic groups included (1) acute cerebrovascular disease, (2) intracranial injury, (3) spinal cord injury, and (4) occlusion or stenosis of precerebral arteries.CONCLUSION: Acute cerebrovascular disease, intracranial injury, spinal cord injury, and occlusion/stenosis of precerebral arteries requiring emergency neurosurgery carry an important nationwide burden in terms of complications, deaths, charges, and LOS. Efforts in prevention and/or treatment of these conditions should continue.

surgery,clinical neurology
112 Impact of COVID-19 on Neurosurgical Utilization and Reimbursement

Michael Stephen Rallo,Anil Nanda,Richard P. Menger

DOI: https://doi.org/10.1227/neu.0000000000002809_112

IF: 5.315

2024-04-01

Neurosurgery

Abstract:INTRODUCTION: The COVID-19 pandemic required significant adaptations in healthcare operations to preserve limited resources and mitigate viral spread. This included the postponement of non-emergent services, including elective surgical procedures, in the Spring/Summer of 2020. Additionally, patients may have avoided or delayed medical care even after the mandatory postponement due to fear of infection. METHODS: We analyzed public data summarizing neurosurgical services provided to Medicare beneficiaries. Annual number of services rendered, beneficiaries treated, and payments received by neurosurgeons were compared between 2019 and 2020 via Students’ T-test and Wilcoxon Rank-Sum tests. Procedures were categorized by location, pathology, and/or approach to identify patterns in the types of procedures most heavily impacted. Pearson's linear regression was used to determine the relationship between the stringency of Covid-19 restrictions and the change in services. RESULTS: From 2019 to 2020, there was a 12.27% decrease in the aggregate number of services rendered by neurosurgeons corresponding to a 12.48% decrease in total Medicare payment. In a matched cohort of 4,649 neurosurgeons active in both 2019 and 2020, the average number of annual services per neurosurgeon declined by 12.40% with a concomitant decrease in payment by 12.77%. This corresponded to an average per-neurosurgeon loss of $17,455.43 in Medicare-related income. Nationally, functional, sellar/parasesellar, and open cerebrovascular surgeries exhibited the largest reduction in volume (all >20%). In contrast, endovascular procedures only declined by 5.5%. There was a weak but significant trend toward larger reduction in volume in states with more stringent Covid-19 restrictions (R = -0.357, p = 0.010). CONCLUSIONS: Neurosurgeons experienced significant reductions in case volume and income during the first year of the Covid-19 pandemic. The magnitude of impact appears to be influenced, at least in part, by the stringency of state-level restrictions.

surgery,clinical neurology
Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system

Conor M Maxwell,Akash M Bhat,Samantha J Falls,Matthew Bigbee,Yue Yin,Sricharan Chalikonda,David L Bartlett,Hiran C Fernando,Casey J Allen

DOI: https://doi.org/10.1016/j.xjon.2023.11.010

2023-11-24

JTCVS Open

Abstract:Objective: We used a framework to assess the value implications of thoracic surgeon operative volume within an 8-hospital health system. Methods: Surgical cases for non-small cell lung cancer were assessed from March 2015 to March 2021. High-volume (HV) surgeons performed >25 pulmonary resections annually. Metrics include length of stay, infection rates, 30-day readmission, in-hospital mortality, median 30-day charges and direct costs, and 3-year recurrence-free and overall survival. Multivariate regression-based propensity scores matched patients between groups. Metrics were graphed on radar charts to conceptualize total value. Results: All 638 lung resections were performed by 12 surgeons across 6 hospitals. Two HV surgeons performed 51% (n = 324) of operations, and 10 low-volume surgeons performed 49% (n = 314). Median follow-up was 28.8 months (14.0-42.3 months). Lobectomy was performed in 71% (n = 450) of cases. HV surgeons performed more segmentectomies (33% [n = 107] vs 3% [n = 8]; P < .001). Patients of HV surgeons had a lower length of stay (3 [2-4] vs 5 [3-7]; P < .001) and infection rates (0.6% [n = 1] vs 4% [n = 7]; P = .03). Low-volume and HV surgeons had similar 30-day readmission rates (14% [n = 23] vs 7% [n = 12]; P = .12), in-hospital mortality (0% [n = 0] vs 0.6% [n = 1]; P = .33), and oncologic outcomes; 3-year recurrence-free survival was 95% versus 91%; P = .44, and 3-year overall survival was 94% versus 90%; P = 0. Charges were reduced by 28%, and direct costs were reduced by 23% (both P < .001) in the HV cohort. Conclusions: HV surgeons provide comprehensive value across a health system. This multidomain framework can be used to help drive oncologic care decisions within a health system.
Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery

Andrew D Auerbach,Joan F Hilton,Judith Maselli,Penelope S Pekow,Michael B Rothberg,Peter K Lindenauer,Andrew D. Auerbach

DOI: https://doi.org/10.7326/0003-4819-150-10-200905190-00007

IF: 39.2

2009-05-19

Annals of Internal Medicine

Abstract:BACKGROUND: Care from high-volume centers or surgeons has been associated with lower mortality rates in coronary artery bypass surgery, but how volume and quality of care relate to each other is not well understood.OBJECTIVE: To determine how volume and differences in quality of care influence outcomes after coronary artery bypass surgery.DESIGN: Observational cohort.SETTING: 164 hospitals in the United States.PATIENTS: 81,289 patients 18 years or older who had coronary artery bypass grafting from 1 October 2003 to 1 September 2005.MEASUREMENTS: Hospital and surgeon case volumes were estimated by using a data set. Quality measures were defined by whether patients received specific medications and by counting the number of measures missed. Hierarchical models were used to estimate effects of volume and quality on death and readmission up to 30 days.RESULTS: After adjustment for clinical factors, lowest surgeon volume and highest hospital volume were associated with higher mortality rates and lower readmission risk, respectively. Patients who did not receive aspirin (odds ratio, 1.89 [95% CI, 1.65 to 2.16) or beta-blockers (odds ratio, 1.29 [CI, 1.12 to 1.49]) had higher odds for death, after adjustment for clinical risk factors and case volume. Adjustment for individual quality measures did not alter associations between volume and readmission or death. However, if no quality measures were missed, mortality rates at the lowest-volume centers (adjusted mortality rate, 1.05% [CI, 0.81% to 1.29%]) and highest-volume centers (adjusted mortality rate, 0.98% [CI, 0.72% to 1.25%]) were similar.LIMITATION: Because administrative data were used, the quality measures may not replicate measures collected through chart abstraction.CONCLUSION: Maximizing adherence to quality measures is associated with improved mortality rates, independent of hospital or surgeon volume.PRIMARY FUNDING SOURCE: California HealthCare Foundation.

medicine, general & internal
Association between volume and cost in low‐resection volume regions: a population‐level study on pancreatoduodenectomy for pancreatic cancer patients

Ling Li,Nanda Aryal,Khalia Ackermann,Neil Merrett,Arthur Richardson,Johanna I Westbrook,Susan Dunn,Vincent Lam

DOI: https://doi.org/10.1111/ans.19273

IF: 1.7

2024-10-20

ANZ Journal of Surgery

Abstract:The median total cost of patients undergoing pancreaticoduodenectomies (PDs) at high‐volume hospitals was 88% of the median cost at low‐volume hospitals. This inverse relationship held true after adjusting for patient and clinical factors. Similarly, the three major cost components: employee cost, operating cost, and other costs, were all lower at high‐volume hospitals. Background Pancreatoduodenectomy (PD) is a highly complex, invasive, and costly surgical procedure. Limited evidence on the PD volume‐cost relationship in countries with a low population density exists. This study aimed to investigate this issue in Australia. Methods This retrospective cohort study included pancreatic cancer patients who had a PD at any public hospital in New South Wales, Australia between 2016 and 2019. The primary outcome was the total hospital cost during PD admission (not including patient financial burden). Study hospitals were grouped into low‐volume hospitals (LVHs; <10 PDs per annum) or high‐volume hospitals (HVHs). Multivariable modelling was applied to examine the association between volume and cost. Results Of 443 PDs, the median total hospital cost per patient at HVHs was AU 62859; P = 0.001). After adjusting for available patient and clinical factors, the total cost per patient at LVHs was 22% higher than that of HVHs (adjusted estimate: 1.22, 95% CI: 1.08–1.37; P = 0.002). Similar patterns were found in three main cost components: 24% higher employee cost at LVHs than at HVHs (1.24, 95% CI: 1.10–1.41; P

surgery
Effects of the COVID-19 Pandemic on Operative Volume and Residency Training at Two Academic Neurosurgery Centers in New Orleans

Mitchell D Kilgore,Tyler Scullen,Mansour Mathkour,Rishawn Dindial,Christopher Carr,Tyler Zeoli,Cassidy Werner,Lora Kahn,Cuong J Bui,Joseph R Keen,Christopher M Maulucci,Aaron S Dumont

DOI: https://doi.org/10.1016/j.wneu.2021.03.122

Abstract:Background: Medical subspecialties including neurosurgery have seen a dramatic shift in operative volume in the wake of the coronavirus disease 2019 (COVID-19) pandemic. The goal of this study was to quantify the effects of the COVID-19 pandemic on operative volume at 2 academic neurosurgery centers in New Orleans, Louisiana, USA from equivalent periods before and during the COVID-19 pandemic. Methods: A retrospective review was conducted analyzing neurosurgical case records for 2 tertiary academic centers from March to June 2020 and March to June 2019. The records were reviewed for variables including institution and physician coverage, operative volume by month and year, cases per subspecialty, patient demographics, mortality, and morbidity. Results: Comparison of groups showed a 34% reduction in monthly neurosurgical volume per institution during the pandemic compared with earlier time points, including a 77% decrease during April 2020. There was no change in mortality and morbidity across institutions during the pandemic. Conclusions: The COVID-19 pandemic has had a significant impact on neurosurgical practice and will likely continue to have long-term effects on patients at a time when global gross domestic products decrease and relative health expenditures increase. Clinicians must anticipate and actively prepare for these impacts in the future.
Improved postoperative outcomes in pediatric major surgery: evidence from hospital volume analysis

Mingyang Sun,Wan-Ming Chen,Szu-Yuan Wu,Jiaqiang Zhang

DOI: https://doi.org/10.1007/s00431-023-05308-2

Abstract:This study aimed to examine the association between hospital volume and postoperative outcomes in pediatric major surgery using a nationwide database. The study included pediatric patients who underwent first major elective inpatient surgery and hospitalization for more than 1 day. The results showed no significant difference in the risk of 30-day postoperative mortality based on hospital volume. However, patients in the middle- and high-volume groups had significantly lower rates of 30-day major complications, particularly deep wound infection. In terms of 90-day postoperative outcomes, patients in the high-volume group had a significantly lower risk of mortality and lower rates of major complications, particularly deep wound infection, pneumonia, and septicemia. Conclusions: The study suggests that pediatric patients undergoing major surgery in high and middle-volume groups have better outcomes in terms of major complications compared to the low-volume group. What is Known: • Limited evidence exists on the connection between hospital volume and pediatric surgery outcomes. What is New: • A Taiwan-based study, using national data, found that high and middle hospital-volume groups experienced significantly lower rates of major complications within 30 and 90 days after surgery. • High-volume hospitals demonstrated a substantial decrease in the risk of 90-day postoperative mortality. • The study underscores the importance of specialized pediatric surgical centers and advocates for clear guidelines for hospital selection, potentially improving outcomes and informing future health policies.
Relationship between hospital surgical volume and the perioperative esophagectomy costs for esophageal cancer: a nationwide administrative claims database study

Takashi Sakamoto,Tatsuto Nishigori,Rei Goto,Koji Kawakami,Takeo Nakayama,Shigeru Tsunoda,Shigeo Hisamori,Koya Hida,Kazutaka Obama

DOI: https://doi.org/10.1007/s10388-024-01092-6

2024-10-01

Esophagus

Abstract:Numerous studies have described positive relationships between hospital volume (HV) and clinical outcomes in highly complex procedures, including esophagectomies. Although the centralization of surgery has been considered a possible solution for improving clinical outcomes, the HV impact on perioperative healthcare costs is unknown. This study aimed to determine the relationship between HV and perioperative healthcare costs for patients undergoing esophagectomy for esophageal cancer.

gastroenterology & hepatology
Impact of Surgeon Volume on Outcomes and Expenditure Among Medicare Beneficiaries Undergoing Liver Resection: the Effect of Minimally Invasive Surgery

Kota Sahara,Katiuscha Merath,J. Madison Hyer,Diamantis I. Tsilimigras,Anghela Z. Paredes,Ayesha Farooq,Rittal Mehta,Lu Wu,Eliza W. Beal,Susan White,Itaru Endo,Timothy M. Pawlik

DOI: https://doi.org/10.1007/s11605-019-04323-9

2019-07-19

Journal of Gastrointestinal Surgery

Abstract:<h3 class="Heading">Background</h3><p class="Para">Although the role of annual surgeon volume on perioperative outcomes after liver resection (LR) has been investigated, there is a paucity of data regarding the impact of surgeon volume on outcomes of minimally invasive LR (MILR) versus open LR (OLR).</p><h3 class="Heading">Methods</h3><p class="Para">Patients undergoing LR between 2013 and 2015 were identified in the Medicare inpatient Standard Analytic Files. Patients were classified into three groups based on surgeons' annual caseload: low (≤ 2 cases), medium (3–5 cases), or high (≥ 6 cases). Short-term outcomes and expenditures of LR, stratified by surgeon volume and minimally invasive surgery (MIS), were examined.</p><h3 class="Heading">Results</h3><p class="Para">Among 3403 surgeons performing LR on 7169 patients, approximately 90% of surgeons performed less than 5 liver resections per year for Medicare patients. Only 7.1% of patients underwent MILR (<em class="EmphasisTypeItalic">n</em> = 506). After adjustment, the likelihood of experiencing a complication and death within 90 days decreased with increasing surgeon volume. Outcomes of open and MILR among low- or high-volume surgeon groups, including rates of complications, 30- and 90-day readmission and mortality were similar. However, the difference of average total episode payment between open and MIS was higher in the high-volume surgeon group (low volume: $2929 vs. medium volume: $2333 vs. high volume: $7055).</p><h3 class="Heading">Conclusion</h3><p class="Para">Annual surgeon volume was an important predictor of outcomes following LR. MILR had comparable results to open LR among both the low- and high-volume surgeons.</p>

gastroenterology & hepatology,surgery

The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.

295 High Volume Centers Provide Superior Value of Care in the Surgical Treatment of Malignant Brain Tumor

Characteristics and outcomes of patients treated with cervical spine fusion at high volume hospitals

Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection

Drivers of Cost for Pancreatic Surgery: It’s Not About Hospital Volume

[Peptide histidine-isoleucine and and its human analogue peptide histidine-methionine: localization, receptors and biological function].

114 Compliance with Federal Price Transparency Rules at US Hospitals With Neurosurgical Training Programs

Volume Alone Does Not Predict Quality Outcomes in Hospitals Performing Pediatric Cardiac Surgery

Hospital resources are associated with value-based surgical performance

Demystifying the association of center-level operative trauma volume and outcomes of emergency general surgery

Does healthcare system device volume correlate with price paid for spinal implants: a cross-sectional analysis of a national purchasing database

High-Volume Hospital Had Lower Mortality of Severe Intracerebral Hemorrhage Patients

The Nationwide Burden of Neurological Conditions Requiring Emergency Neurosurgery

112 Impact of COVID-19 on Neurosurgical Utilization and Reimbursement

Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system

Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery

Association between volume and cost in low‐resection volume regions: a population‐level study on pancreatoduodenectomy for pancreatic cancer patients

Effects of the COVID-19 Pandemic on Operative Volume and Residency Training at Two Academic Neurosurgery Centers in New Orleans

Improved postoperative outcomes in pediatric major surgery: evidence from hospital volume analysis

Relationship between hospital surgical volume and the perioperative esophagectomy costs for esophageal cancer: a nationwide administrative claims database study

Impact of Surgeon Volume on Outcomes and Expenditure Among Medicare Beneficiaries Undergoing Liver Resection: the Effect of Minimally Invasive Surgery